top of page
Nencki_Liang1_edited.jpg
vectorstock_18695401.jpg
Nencki Institute of Experimental Biology PAS
IMG20251219133345_edited_edited.jpg

"Dare to dream, strive to achieve"

  • LinkedIn
  • bluesky-social-logo
  • X
  • weibo

My education

Jul 06 - Aug 09

University of Malaya, Malaysia

  • Bsc Biomedical Science

Sep 10 - Dec 11

University of Nottingham, UK

  • Msc Oncology

Oct 11 - Oct 16

University College Cork, Ireland

  • PhD Cancer Biology

My journey

Oct 13 - Sep 15

University of Glasgow, UK

  • Visiting PhD scholar 

Jun 16 - Feb 26

Ghent University, Belgium

  • Postdoc researcher

Sep 26 - present

Nencki Institute of Experimental Biology PAS, Poland

  • Group leader (PI)

  • LinkedIn
  • bluesky-social-logo
  • X
  • weibo
Contributions to science
Current research
  • The thymus is constantly seeded by circulating hematopoietic progenitors that are originated from the bone marrow. These thymus-seeding progenitors (TSPs) undergo stepwise differentiation to generate immunocompetent T cells. I contributed to the identification and characterization of human TSP1 and TSP2 subsets. I discovered that cellular crosstalk-mediated activation of tumor necrosis factor receptor 2 (TNFR2) is important to expand human T cell precursors.

  • The mammalian Tribbles (TRIB) family, TRIB1-3, is classified as pseudokinases that act as adaptor molecules to regulate and integrate a wide range of signaling pathways. I contributed to the understanding of the roles of TRIB1-3 in malignant hematopoiesis. Despite being recognized as a myeloid oncogene, I discovered that TRIB2 has a tumor suppressor function in the development of NOTCH1-driven T-cell acute lymphoblastic leukemia.

  • ​​Liang's lab is dedicated to unravel the pleiotropic roles of TNFR2 in human normal and malignant hematopoiesis, thereby contributing to a deeper understanding of human blood cell development and pathogenesis of blood diseases. Ultimately, we aim to advance the targeting of TNFR2 in the generation of novel blood cell therapy products and the clinical therapeutics for blood diseases. 

​

  • In the context of human hematopoiesis, we are interested in:​

  1. the regulation of TNFRSF1B/TNFR2 (mis)expressions

  2. cellular crosstalk that activates TNFR2

  3. signaling pathways mediated by TNFR2 activation

  4. biological and clinical relevance of TNFR2 (mis)expression  

​​​

  • LinkedIn
  • bluesky-social-logo
  • X
  • weibo
Meet the Team
Liang's lab will officially open from September 2026 onwards! 

Please stay  tuned for recruitment announcement.
  • postdoctoral researcher(s)
  • PhD student(s)
  • lab manager
  • LinkedIn
  • bluesky-social-logo
  • X
  • weibo
News
IMG20260618121653.jpg
Nencki Institute of Experimental Biology PAS

Nencki Institute of Experimental Biology PAS

3 Pasteur Street

02-093 Warsaw

Poland

 

© 2035 by My Site. Powered and secured by Wix 

 

bottom of page